Mowery & Schoenfeld Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$40K Sell
111
-27
-20% -$9.24K 0.05% 153
2026
Q1
$48.4K Sell
138
-46
-25% -$16.4K 0.07% 127
2025
Q4
$60.1K Buy
184
+53
+40% +$16.8K 0.09% 127
2025
Q3
$36.8K Sell
131
-11
-8% -$3.19K 0.06% 137
2025
Q2
$39.5K Hold
142
0.06% 127
2025
Q1
$44.1K Buy
142
+21
+17% +$6.2K 0.09% 139
2024
Q4
$31.5K Buy
121
+86
+246% +$25.5K 0.06% 147
2024
Q3
$11.3K Buy
+35
New +$11.4K 0.02% 169

Other funds holding AMGN

Mowery & Schoenfeld Wealth Management's AMGN Position: Q2 2026 in Review

Mowery & Schoenfeld Wealth Management reduced its Amgen (AMGN) stake by 20% in Q2 2026, selling an estimated $9.24K and leaving 111 shares worth $40K. The position accounts for 0.05% of the portfolio, ranked #153.

Mowery & Schoenfeld Wealth Management first reported a position in AMGN in Q3 2024 and has held it in 8 quarters since. The position peaked at $60.1K in Q4 2025. 2,223 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Mowery & Schoenfeld Wealth Management held 111 shares of Amgen worth $40K as of Q2 2026.
  • Mowery & Schoenfeld Wealth Management sold 27 Amgen shares in Q2 2026, an estimated $9.24K.
  • Amgen made up 0.05% of Mowery & Schoenfeld Wealth Management's portfolio in Q2 2026, its #153 holding.
  • Mowery & Schoenfeld Wealth Management first reported a position in Amgen in Q3 2024 and has held it in 8 quarters since.
  • Mowery & Schoenfeld Wealth Management's Amgen position peaked at $60.1K in Q4 2025.
  • 2,223 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Mowery & Schoenfeld Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.